Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis

Journal of the National Cancer Institute

Volumn 94, Issue 1, 2002, Pages 17-25

  Nemeth, Jeffrey A ^a   Yousif, Rafid ^a   Herzog, Michael ^a   Che, Mingxin ^a   Upadhyay, Jyoti ^a   Shekarriz, Bijan ^a   Bhagat, Sunita ^a   Mullins, Chadwick ^a   Fridman, Rafael ^a   Cher, Michael L ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BATIMASTAT; CALCIUM; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD VESSEL; BONE BIOPSY; BONE MATRIX; BONE METASTASIS; BONE MINERALIZATION; BONE REMODELING; BONE TISSUE; BONE TURNOVER; CALCIUM TRANSPORT; CANCER GROWTH; CANCER INVASION; CELL COUNT; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DENSITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMPLANT; IN VITRO STUDY; IN VIVO STUDY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; ORGAN CULTURE; OSTEOCLAST; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TRABECULAR BONE; TUMOR CELL;

EID: 0037005993     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/94.1.17     Document Type: Article

References (51)

1. Mechanisms of metastasis: Prostate cancer
2. Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved
3. Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients
4. Total and regional bone mass and biochemical markers of bone remodeling in metastatic prostate cancer
5. Comparison of markers of bone formation and resorption in prostate cancer patients to predict bone metastasis
6. Urinary pyridinoline and deoxypridinoline as potential markers of bone metastasis in patients with prostate cancer
7. MMP-2: Expression, activation and inhibition
8. An odyssey from breast to bone: Multi-step control of mammary metastases and osteolysis by matrix metalloproteinases
9. Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension
10. Increased incidence of matrix metalloproteinases in urine of cancer patients
11. Synthetic matrix metalloproteinase inhibitor, BB-94, inhibits the invasion of neoplastic human prostate cells in a mouse model
12. Effect of matrix metalloproteinase inhibitors on tumor growth and spontaneous metastasis
13. Requirement for matrix metalloproteinase-9 (gelatinase B) expression in metastasis by murine prostate carcinoma
14. Membrane type 1-matrix metalloproteinase (MT1-MMP) and MMP-2 immunolocalization in human prostate: Change in cellular localization associated with high-grade prostatic intraepithelial neoplasia
15. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules
16. The migration of purified osteoclasts through collagen is inhibited by matrix metalloproteinase inhibitors
17. Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones
18. Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone
19. Initiation of osteoclast bone resorption by interstitial collagenase
20. Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts
21. The collagenolytic activity of cathepsin K is unique among mammalian proteinases
22. Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase
23. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts
24. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes
25. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover
26. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone
27. Matrix metallo-proteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice
28. Phorbol ester-induced cell surface association of matrix metalloproteinase-9 in human MCF10A breast epithelial cells
29. Persistence of human vascular endothelium in experimental human prostate cancer bone tumors
30. Immunohistochemical studies of activated matrix metalloproteinase-2 (MMP-2a) expression in human prostate cancer
31. Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue
32. In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer
33. Human metastatic prostate PC3 cell lines degrade bone using matrix metalloproteinases
34. Mechanisms of bone metastasis
35. Recruitment of osteoclast precursors by purified bone matrix constituents
36. Proteoglycans as modulators of growth factor activities
37. Role of proteases in osteoclastic resorption
38. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases
39. Mechanisms of the development of osteoblastic metastases
40. Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo
41. Direct resorption of bone by human breast cancer cells in vitro
42. Direct osteolysis induced by metastatic murine melanoma cells: Role of matrix metalloproteinases
43. Osteoid: An ultrastructural study
44. Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts
45. Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact
46. Mammalian collagenase predisposes bone surfaces to osteoclastic resorption
47. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines
48. Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts
49. The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts
50. Integrin function in osteoclasts
51. Bone sialoprotein stimulates in vitro bone resorption